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The cytotoxic, antiplasmodial, and antitrypanosomal activities of two medicinal plants traditionally used
in Cameroon were evaluated. Wood of Ficus elastica Roxb. ex Hornem. aerial roots (Moraceae) and
Selaginella vogelii Spring (Selaginellaceae) leaves were collected from two different sites in Cameroon.
In vitro cell-growth inhibition activities were assessed on methanol extract of plant materials against
Plasmodium falciparum strain 3D7 and Trypanosoma brucei brucei, as well as against HeLa human cervical
carcinoma cells. Criteria for activity were an IC50 value < 10 lg/mL. The extract of S. vogelii did not signif-
icantly reduce the viability of P. falciparum at a concentration of 25 lg/mL but dramatically affected the
trypanosome growth with an IC50 of 2.4 lg/mL. In contrast, at the same concentration, the extract of F.
elastica exhibited plasmodiacidal activity (IC50 value of 9.5 lg/mL) and trypanocidal (IC50 value of
0.9 lg/mL) activity. Both extracts presented low cytotoxic effects on HeLa cancer cell line. These results
indicate that the selected medicinal plants could be further investigated for identifying compounds that
may be responsible for the observed activities and that may represent new leads in parasitical drug
discovery.
 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Natural products have been used since millennia for the treat-
ment of human diseases and as a result, a large proportion of cur-
rent drugs in modern medicine have been developed from naturalmolecules. The search for new biologically active natural products
continues to be an intense field of research (Newman et al., 2015).
Indeed, the high natural biodiversity represents a broad range of
diverse chemical structures with potentially newmolecules having
promising biological activities. Such new natural molecules can
often serve as chemical templates for the design and the synthesis
of novel drugs.
Plants have historically proven their value as a rich source of
molecules with therapeutic potential and many major current
drugs are natural products-derived compounds (Newman and
Cragg, 2016). The natural products firstly commercialized for ther-
apeutic use are morphine, isolated from Papaver somniferum
(Rosenblum et al., 2008) and aspirin, based on the natural product
salicin from Salix alba (Dias et al., 2012). Since these pioneering
drugs, many other plant-derived molecules have been added to
the current therapeutic arsenal of medicine, such as artemisinin
from Artemisia annua used against malaria, capsaicin from
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dronabinol and cannabidiol from Cannabis sativa used inter alia to
treat nausea and vomiting caused by chemotherapy, paclitaxel
from Taxus brevifolia for treating lung, ovarian and breast cancers,
silymarin from the seeds of Silybum marianum for the treatment of
liver diseases, and tiotropium, a derivative of atropine from Atropa
belladonna used as a bronchodilator in the management of chronic
obstructive pulmonary disease (Veeresham, 2012).
Healing with medicinal plants is the basis of traditional medi-
cine (Neuwinger, 2000). Although having a long tradition in alter-
native medicine, Cameroon has been largely underexplored for
new biologically active natural products. The biological effects of
extracts from two Cameroonian plant materials were here investi-
gated. The Moraceae plant family includes Ficus as one of the main
genus with biological activities already described such as antiplas-
modial (Muregi et al., 2003), antioxidant (Phan et al., 2012), anti-
cancer (Mbosso et al., 2012, 2015, 2016a, 2016b), antimicrobial
(Mbosso et al., 2012, 2015, 2016b), antiulcer (Galati et al., 2001),
antidiarrhoeal (Mandal and Kumar, 2002), anti-pyretic (Rao et al.,
2002) and gastroprotective (Rao et al., 2008). Note that the latex
of some species of Ficus is exploited in traditional folk medicine
for its antihelmintic activity in South and Central America (de-
Amorin et al., 1999). The parasiticidal property of this genus has
been ascribed to the presence of ficin (Pistelli et al., 2000) and it
was also demonstrated that the latex of Ficus elastica Roxb. ex Hor-
nem. (Moraceae) showed a significant antischistosomal activity
(Seif el-Din et al., 2014). Leaf extract of F. elastica is employed as
a diuretic agent besides treating skin infections and allergies
(Phan et al., 2012).
Different species of Selaginella genus are exploited in traditional
medicine for their anti-nociceptive, anti-inflammatory, anti-
mutagenic, anti-spasmodic, cytotoxic, immune and antiretroviral
properties (Jiofack et al., 2010). In addition, chemo-taxonomic
studies have revealed that the genus Selaginella contains a variety
of secondary metabolites namely alkaloids, phenolic compounds,
terpenoids and many other classes of compounds exhibiting
antioxidant, anticancer, antimicrobial, anti-protozoal, antiviral,
anti-inflammatory and antiallergic properties (Morat, 1997).
Hence, species of Selaginella genus have a fairly large spectrum of
activity related to medication spanning cancer, cardiovascular dis-
eases, diabetes, gastritis, hepatitis, skin diseases and urinary tract
infections (Almeida et al., 2013). To the best of our knowledge, very
few biological and phytochemical studies were conducted on the
species Selaginella vogelii Spring (Selaginellaceae). The aim of the
present study is to evaluate two medicinal plant extracts from
Cameroon, i.e. the wood of F. elastica aerial roots and S. vogelii
leaves, for their in vitro antiplasmodial, antitrypanosomal and cyto-
toxity potential.2. Experimental
2.1. Plant materials
The wood of F. elastica aerial roots was collected in Yaoundé in
August 2015 and S. vogelii leaves in Ngwei I in May 2015. The
plant’s identification was established by a member of the National
Herbarium of Cameroon (NHC), where voucher specimens (No.
65646 HNC for F. elastica and No. 12000 HNC for S. vogelii) were
deposited. After Air-drying, the plants materials were crushed into
a fine powder by using an electric grinder.2.2. Extraction
Macerate of the dried aliquot (5.50 kg of F. elastica and 7.50 kg
of S. vogelii) was obtained using methanol (20 and 30 L, respec-tively) on two accounts for 48 h at room temperature (27 ± 2 C)
(Mohamad et al., 2011). After filtration (Whatman Number One,
320 mm, 4 lm) and evaporation at low pressure using a rotary
evaporator (bath at 40 C), 15 g and 280 g of extracts were
obtained for F. elastica and S. vogelii, respectively.
2.3. Antiplasmodial activity
Malaria parasites (Plasmodium falciparum strain 3D7) were
maintained in RPMI 1640 medium containing 2 mM L-glutamine
and 25 mM Hepes (Lonza). The medium was further supplemented
with 5% Albumax II, 20 mM glucose, 0.65 mM hypoxanthine,
60 lg/mL gentamycin and 2–4% hematocrit human red blood cells.
The parasites were cultured at 37 C under an atmosphere of 5%
CO2, 5% O2, 90% N2 in sealed T25 or T75 culture flasks. For screening
samples against malaria parasites, 25 lg/mL of natural extracts
were added to parasite cultures in 96-well plates and incubated
for 48 h in a 37 C CO2 incubator. After 48 h, the plates were
removed from the incubator and 20 lL of culture were removed
from each well and mixed with 125 lL of a mixture of Malstat
solution and NBT/PES solution in a fresh 96-well plate. The parasite
lactate dehydrogenase (pLDH) activity was meseared by absor-
bance at 620 nm in a 96 well plate reader. The Abs620 reading in
each well was thus an indication of both the pLDH activity and
the number of parasites in that well.
2.4. Antitrypanosomal activity
Trypanosoma brucei (T. b.) parasites are the causative agents of
African sleeping sickness (human African trypanosomiasis) in
humans and Nagana (animal African trypanosomiasis) in cattle.
The subspecies responsible for Nagana, Trypanosoma brucei brucei
(T.b. brucei) is not infective to humans and is commonly used for
drug screening. To assess antitrypanocidal activity, in vitro cultures
of T.b. brucei in 96-well plates were performed at a fixed concentra-
tion of 25 lg/mL for natural extracts (unless otherwise stated).
After an incubation period of 48 h, the number of parasites surviv-
ing drug exposure was determined by adding a resazurin based
reagent. The reagent contains resazurin which was reduced to
resorufin by living cells. Resorufin is a fluorophore (Excitation560/
Emission590) and can thus be quantified in a multiwell fluorescence
plate reader.
2.5. Cytotoxic activity
To assess the overt cytotoxicity of the extracts, they were
incubated at a fixed concentration of 62.5 lg/mL (unless otherwise
stated) in 96-well plates containing HeLa (human cervix adenocar-
cinoma, maintained in a culture medium made of Dulbecco’s Mod-
ified Eagle’s Medium (DMEM) with 5 mM L-glutamine (Lonza),
supplemented with 10% fetal bovine serum (FBS) and antibiotics
(penicillin/streptomycin/fungizone - PSF) cells for 24 h. The
numbers of cells surviving drug exposure were counted using the
resazurin based reagent and resorufin fluorescence quantified
(Excitation560/Emission590) in a multiwell plate reader.
2.6. Single concentration screening
For each compound concentration, % parasitermia or cell viabil-
ity was calculated. Extracts were tested in triplicate wells, and a
standard deviation (SD) was derived. For comparative purposes,
chloroquine (an anti-malarial drug) or emetine (which induced cell
apoptosis) or pentamidine (an existing drug used in the treatment
of trypanosomiasis) was used as a positive control drug standard at
a 0 lM for the first two drugs or at 1 lM in case of pentamidine.
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For each sample, percentage viability was obtained against Log
(extract concentration) and the IC50 (50% inhibitory concentration)
determined from the resulting dose-response curve by non-linear
regression using Prism 5 for Windows, Version 5.02 (graph Pad
Software, Inc) program. For comparative purposes, chloroquine,
pentamidine or emetine were employed as drug standards accord-
ing to the type of test performed. Chloroquine, pentamidine and
emetine yielded IC50 values in the range of 0.00001–100 lM.
Extracts were tested in a range extending from 250 to 0.11 lg/
mL (3-fold-dilutions) for antiplasmodial and antitrypanosomal
assays, and from 125 to 0.057156 lg/mL (also in a 3-fold dilution
series) for cytotoxic assays. In antiplasmodial assay, the R2 coeffi-
cient of determination was calculated to be 0.95, 0.99 and 0.99
for the methanol extract of Selaginella vogelii leaves (EBSVF), the
wood methanol extract of Ficus elastica aerial roots (EBRFE) and
chloroquine, respectively. In antitrypanosomal assay, the coeffi-
cient was R2 = 0.99 for the three samples, EBSVF, EBRFE and pen-
tamidine. In cytotoxic assay, the R2 coefficient was computed as
0.93, 0.99 and 0.98 for EBSVF, EBRFE and emetine, respectively.
3. Results and discussion
3.1. Antiplasmodial activity
As observed in Fig. 1, the methanol extract of S. vogelii leaves
(EBSVF) at a concentration of 25 lg/ml slightly decreased the via-
bility of Plasmodium falciparum (58.3 ± 2.1%) with an IC50 value of
32.2 lg/mL. In contrast, at the same concentration, the wood
methanol extract of F. elastica aerial roots (EBRFE) reduced the via-
bility of Plasmodium falciparum to approximatively 0% with an IC50
value of 9.5 lg/mL, and therefore demonstrated an antiplasmodial
activity. The chloroquine used as reference drug showed an IC50
value of 7.9 nM. However, this result needs to be re-examined in
conjunction with the cytotoxicity results to ensure that the
decrease in viability is not caused by a general cytotoxicity of the
EBRFE extract.
The remarkable activity of quinine and related drugs and the
success of artemisinin have stimulated the search for new plant-
derived antimalarials. A large number of plants have been screened
for antiplasmodial activity (Krettli, 2009). S. Vogelii has not previ-
ously been explored as an antimalarial treatment in traditional
Cameroonian medicine and was selected owing to the cytotoxicFig. 1. Dose-response curveeffect of the genus (Jiofack et al., 2010). Multiple efficacy parame-
ters for in vitro antimalarial activity have been proposed (Cos et al.,
2006). For crude extracts, IC50 values should certainly be below
100 mg/mL (Cos et al., 2006) although most promising antimalarial
extracts exhibit IC50 values under 10 mg/mL (Krettli, 2009; Soh and
Benoit-Vical, 2007). Here, the wood methanol extract of F. elastica
aerial roots (EBRFE) revealed an IC50 value lower than 10 lg/mL
against P. falciparum, arising as a good candidate for further
bioassay-guided fractionation. By comparison, hexane extracts of
F. thonningii were endowed with strong activity against NF54 and
K1 strains of P. Falciparum with IC50 values of 2.7 and 10.4 lg/
mL, respectively (Falade et al., 2014). F. ovata Vahl bark also
demonstrated a high activity with an IC50 value of 4.8 lg/ml
(Bwalya et al., 2011). In contrast, the methanol extract of F. platy-
phylla had a weak activity against 3D7 and K1 strains of P. Falci-
parum with IC50 values of 15.3 and 13.8 lg/mL, respectively
(Shuaibu et al., 2008).
According to a recent study, two bioflavonoids, hinokiflavone
and 2,3-dihydrohinokiflavone, isolated from Selaginella bryopteris
possessed an in vitro anti-protozoal activity against P. falciparum
K1 (IC50 values of 2.3 and 4.5 lM, respectively) (Kunert et al.,
2008). Thus, the weak parasiticidal property of crude extract EBSVF
might be attributed to the presence of these bioflavonoids at low
concentrations. Indeed, it is well-established that the Selaginella
genus is a rich source of steroids, bioflavonoids and lignans
(Almeida et al., 2013). Three fractions (toluene, ethyl acetate and
butanol) obtained from an ethanolic extract of S. Bryopteris, also
showed an antiplasmodial activity against P. falciparum K1 strain
with IC50 values of 4.6, 1.0, and below 5 lg/mL, respectively
(Kunert et al., 2008).
3.2. Antitrypanosomal activity
The methanol extract from S. vogelii leaves (EBSVF) affected the
growth of trypanosomes at 25 lg/mL concentration with a per-
centage of viable parasites estimated to be 0.3 ± 0.1% (see Fig. 2).
The methanol extract of F. elastica (EBRFE) also reduced the viabil-
ity of T. b. brucei at the same concentration, giving 2.0 ± 0.1% of via-
bility, thus exhibiting an antitrypanosomal property. Furthermore,
EBSVF and EBRFE extracts were both in the lower range of IC50 val-
ues (2.4 and 0.9 lg/mL, respectively), whereas the reference drug
pentamidine exhibited an IC50 value of 0.17 nM (Table 1).
The two plants have not previously been used as antitrypanoso-
mial treatment in traditional Cameroonian medicine and werefor antimalarial assay.
Fig. 2. Dose-response curve for trypanosome assay.
Table 1
In vitro assays of the methanol extracts.
Tested extracts or
compounds
Antimalarial Antitrypanosomal Cytotoxicity
IC50 (in lg/mL for extracts and lM for
the reference drugs)
EBSVFa 32.2 2.4 24.5
EBRFEb 9.5 0.9 20.9
Reference drugc 0.0079 0.00017 0.04
IC50: 50% inhibitory concentration, i.e. the concentration of extract/compound that
reduces by 50% the growth or proliferation of cells.
The number of replicates was 3.
a (EBSVF) methanol extract of Selaginella vogelii leaves.
b (EBRFE) wood methanol extract of Ficus elastica aerial roots.
c Reference drugs, i.e. chloroquine, emetine and pentamidine for antimalarial,
cytotoxicity and antitrypanosomal activities, respectively used at a concentration of
10 lM for the first two drugs or at 1 lM in case of pentamidine.
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the parasiticidal property of F. elastica (Pistelli et al., 2000; Seif el-
Din et al., 2014). Interestingly, F. elastica has been traditionally
used for treating skin infections and allergies, as well as a diuretic
agent (Phan et al., 2012) while the vogelii genus has been employed
to treat cancer, cardiovascular diseases, diabetes, gastritis, hepati-
tis, skin disorders, and urinary tract infections (Almeida et al.,
2013). However, no antitrypanosomal activities have been
reported to date from both plants.
According to Weniger et al., ginkgetin is the second most stud-
ied bi-flavonoid of the Selaginella genus. This compound has an
in vitro antiprotozoal property against T. Cruzi (Weniger et al.,
2006). Hinokiflavone isolated from S. bryopteris also possesses an
in vitro antiprotozoal activity against Trypanosoma sp (Weniger
et al., 2006; Kunert et al., 2008). The crude extract EBSVF may also
contain a high concentration of such bioflavonoids responsible for
the antiprotozoal activity in the S. vogelii species. On the other
hand, three fractions of ethanolic extract from S. bryopteris
(toluene, ethyl acetate and butanol) did not show antitrypanoso-
mal activities against T. Brucei rhodesiene, yielding IC50 values of
24.1, 12.4 and 28.5 lg/mL, respectively and against T. Cruzi with
IC50 values higher than 30, 20.5, and above 30 lg/mL, respectively
(Kunert et al., 2008).
There is very little information available on the antitrypanoso-
mal effects of the genus Ficus. Methanol extract stem bark of Ficus
platyphylla showed an antitrypanosomal activity with minimum
lethal concentrations of 25 lg/ml (Sawadogo et al., 2012). Metha-nol stem bark extract of Ficus sycomorus, ceased T. b. bruceimotility
in vitro within the incubation time of less than one hour but with
low IC50 value (4 mg/mL) (Nwodo et al., 2015).3.3. Cytotoxic activity
The methanol extract of S. vogelii leaves (EBSVF) and the wood
methanol extract of F. elastica aerial roots (EBRFE) showed IC50 val-
ues at 20 lg/mL, whereas standard drug emetine exhibited an IC50
value of 0.04 lM (Table 1 and Fig. 3). A very low cytotoxic activity
against HeLa cells was thereby observed for both extracts. Indeed,
none of the two extracts were cytotoxic at 62.5 lg/mL.
These plants have rather a great significance for their traditional
use in the treatment of other pathologies than cancer. Ficus thon-
ningii and F. platyhylla showed very weak cytotoxicity with IC50
values 1500.0 lg/ml on NBMH mammalian cell lines (Shuaibu
et al., 2008). The ethanolic extracts from S. bryopteris did not dis-
play significant cytotoxic activity against the rat skeletal myoblast
cell line (L-6 cells) with IC50 values >90, 32.6, and >90 lg/mL, for
extracting solvents, toluene, ethyl acetate, and butanol, respec-
tively (Kunert et al., 2008).
However, the very weak cytotoxic activity observed here for
EBSVF is contrary to that observed for other species of the Selagi-
nella genus. For instance, in previous work, two compounds (a
biflavanone, 2,200,3,300-tetrahydrorobustaflavone 7,40,700-trimethyl
ether and the biflavonoid, robustaflavone 7,40,700-trimethyl ether)
isolated from the methanol extract of S. doederleinii (whole plants)
exhibited a good cytotoxic activity against the colorectal carcinom
cells HCT116 with IC50 values of 19.1 and 15.6 lg/mL, respectively,
and against the bronchioalveolar carcinoma NCI-H358 with IC50
values of 23.5 and 20.1 lg/mL, respectively (Lee et al., 2008). The
ethyl acetate extract of S. moellendorffii inhibited the growth of
ovarian adenocarcinoma cancer cells (Setyawan, 2011). S. delicatula
behaves like an anticancer agent (Chen et al., 2005) as well as
S. doederleinii (Li et al., 2014). Water extract of S. doederleinii has
a moderate antimutagenic activity against the benzo[a]pyrene-
induced mutation associated with cancer cell progression (Lee
and Lin, 1988). S. labordeiwas reported to have anti cancer features
(Tan et al., 2009).
S. tamariscina is problably the most powerful medicinal plant
from the Selaginella genus. This plant is widely employed as an
anticancer, antioxidant and as an anti-inflammatory agent
(Le et al., 2012). It also possesses the following properties:
anti-bacterial, anti-hypertensive, and anti-hyperglycemic effects
Fig. 3. Dose-response curve for cell toxicity assay.
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cancer activity, S. tamariscina was reported to exhibit several func-
tions: it can inhibit the invasion and metastatic activities of lung
cancer cells, as well as the growth of metastasic A549 cell and
Lewis lung carcinoma (Yang et al., 2007); shows significant tumo-
ricidal effects against cultured HL-60 human leukemia cells (Lee
et al., 1999); induces the expression of tumor suppressor gene of
p53 (Lee et al., 1996); degrades U937 leukemia cancer cells (Lee
et al., 1996; Yang et al., 2007); reduces the proliferation of nucleus
antigen cell from stomach epithelium (Lee et al., 1999); and acts as
chemo-preventive for gastric cancer (Lee et al., 1999).
Finally, as EBRFE and EBSVF extracts showed substantial
antiprotozoal and antitrypanosomal activities without toxicity on
HeLa cells which suggested that the effects on parasite cultures
may not arise from a general cytotoxic effect of crude extracts.4. Conclusions
This study has demonstrated that the crude extracts of the
wood of F. elastica aeriel roots and S. vogelii leaves presented low
antiplasmodial and very important antitrypanosomal activities
associated with a low cytotoxicity. The comparison between the
parasiticidal and cytotoxicity effects suggests that the decreased
viability of parasites may not be caused by a general cytotoxicity
of the extracts. These results indicate that the selected medicinal
plants should be explored more actively in order to isolate the
main compounds responsible for the parasiticidal action. It is
important to mention that to the best of our knowledge, this study
represents the first report on cytotoxic, antimalarial and antitry-
panosomal evaluation for the wood of F. elastica aerial roots and
S. vogelii leaves. The obtained results support to some extent the
traditional uses of these plants for the treatment of parasitic dis-
eases. Isolation, purification, and structure elucidation of con-
stituents from these plants are warranted to support discovery of
novel antiplasmodial and/or antitrypanosomal compounds.
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